IRIS Accounts Production v24.1.9.2 11328898 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh113288982023-04-30113288982024-04-30113288982023-05-012024-04-30113288982022-04-30113288982022-05-012023-04-30113288982023-04-3011328898ns15:EnglandWales2023-05-012024-04-3011328898ns14:PoundSterling2023-05-012024-04-3011328898ns10:Director12023-05-012024-04-3011328898ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3011328898ns10:SmallEntities2023-05-012024-04-3011328898ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3011328898ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3011328898ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3011328898ns10:FullAccounts2023-05-012024-04-3011328898ns10:OrdinaryShareClass12023-05-012024-04-3011328898ns10:OrdinaryShareClass22023-05-012024-04-3011328898ns5:CurrentFinancialInstruments2024-04-3011328898ns5:CurrentFinancialInstruments2023-04-3011328898ns5:ShareCapital2024-04-3011328898ns5:ShareCapital2023-04-3011328898ns5:RetainedEarningsAccumulatedLosses2024-04-3011328898ns5:RetainedEarningsAccumulatedLosses2023-04-3011328898ns10:RegisteredOffice2023-05-012024-04-3011328898ns5:ComputerEquipment2023-05-012024-04-3011328898ns5:ComputerEquipment2023-04-3011328898ns5:ComputerEquipment2024-04-3011328898ns5:ComputerEquipment2023-04-3011328898ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3011328898ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3011328898ns5:DeferredTaxation2023-04-3011328898ns5:DeferredTaxation2023-05-012024-04-3011328898ns5:DeferredTaxation2024-04-3011328898ns10:OrdinaryShareClass12024-04-3011328898ns10:OrdinaryShareClass22024-04-30113288981ns10:Director12023-04-30113288981ns10:Director12022-04-30113288981ns10:Director12023-05-012024-04-30113288981ns10:Director12022-05-012023-04-30113288981ns10:Director12024-04-30113288981ns10:Director12023-04-30
REGISTERED NUMBER: 11328898 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

Medical Simulation Services Limited

Medical Simulation Services Limited (Registered number: 11328898)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Medical Simulation Services Limited (Registered number: 11328898)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,413 2,554

CURRENT ASSETS
Debtors 5 2,200 2,001
Cash at bank 19,433 16,779
21,633 18,780
CREDITORS
Amounts falling due within one year 6 18,481 14,587
NET CURRENT ASSETS 3,152 4,193
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,565

6,747

PROVISIONS FOR LIABILITIES 7 648 485
NET ASSETS 5,917 6,262

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 5,817 6,162
SHAREHOLDERS' FUNDS 5,917 6,262

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medical Simulation Services Limited (Registered number: 11328898)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 September 2024 and were signed on its behalf by:





B S Atkinson - Director


Medical Simulation Services Limited (Registered number: 11328898)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

Medical Simulation Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11328898

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Medical Simulation Services Limited (Registered number: 11328898)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 May 2023 4,852
Additions 2,216
Disposals (2,062 )
At 30 April 2024 5,006
DEPRECIATION
At 1 May 2023 2,298
Charge for year 1,357
Eliminated on disposal (2,062 )
At 30 April 2024 1,593
NET BOOK VALUE
At 30 April 2024 3,413
At 30 April 2023 2,554

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 773 -
Other debtors 97 613
Directors' current accounts 1,330 1,388
2,200 2,001

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade creditors - 11,682
Tax 1 1,411
Deferred income 18,000 -
Accrued expenses 480 1,494
18,481 14,587

Medical Simulation Services Limited (Registered number: 11328898)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

7. PROVISIONS FOR LIABILITIES
30.4.24 30.4.23
£    £   
Deferred tax 648 485

Deferred
tax
£   
Balance at 1 May 2023 485
Provided during year 163
Balance at 30 April 2024 648

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.4.24 30.4.23
value: £    £   
50 Ordinary A £1 50 50
50 Ordinary B £1 50 50
100 100

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 April 2024 and 30 April 2023:

30.4.24 30.4.23
£    £   
B S Atkinson
Balance outstanding at start of year 1,388 2,757
Amounts advanced 2,388 2,000
Amounts repaid (2,446 ) (3,369 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,330 1,388

10. ULTIMATE CONTROLLING PARTY

The controlling party is the directors.